ARCHIVES

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

DOD Names Innovator Award Recipients.

April 26, 2002

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

Entire Construction Budget In 1983 Goes to Two Grants; Help May Be On The Way

February 25, 1983

Cytopathologists, NCI Recommend New Method For Pap Smear Reports

August 25, 1989

Van Brings Free Brain MRIs To Capitol Hill; Experts See Enormous Potential For Harm

May 8, 2009

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001